Dongfang Liu

CIK: 0001937915

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (44.4%)

Position reduction

Option Exercises (M)8 (44.4%)

Derivative conversions

Awards (A)2 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NUVB

Nuvation Bio Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

NUVB
Nuvation Bio Inc.
Apr 17, 2026
Exercise(M)
Direct
50K shares at avg. $1.94$97K
NUVB
Nuvation Bio Inc.
Apr 17, 2026
Sale(S)
Direct
50K shares at avg. $5.02$251K
NUVB
Nuvation Bio Inc.
Feb 27, 2026
Award(A)
Stock Option (Right to Buy)
Direct
748.1K shares-
NUVB
Nuvation Bio Inc.
Dec 1, 2025
Sale(S)
Direct
150K shares at avg. $7.82$1.2M
NUVB
Nuvation Bio Inc.
Dec 1, 2025
Exercise(M)
Direct
150K shares at avg. $2.93$440K
NUVB
Nuvation Bio Inc.
Nov 26, 2025
Sale(S)
Direct
10K shares at avg. $8.00$80K
NUVB
Nuvation Bio Inc.
Nov 26, 2025
Exercise(M)
Direct
10K shares at avg. $3.61$36K
NUVB
Nuvation Bio Inc.
Nov 25, 2025
Sale(S)
Direct
10K shares at avg. $7.50$75K
NUVB
Nuvation Bio Inc.
Nov 25, 2025
Exercise(M)
Direct
10K shares at avg. $3.61$36K
NUVB
Nuvation Bio Inc.
Nov 20, 2025
Sale(S)
Direct
20K shares at avg. $7.00$140K
NUVB
Nuvation Bio Inc.
Nov 20, 2025
Exercise(M)
Direct
20K shares at avg. $1.87$37K
NUVB
Nuvation Bio Inc.
Nov 19, 2025
Exercise(M)
Direct
15K shares at avg. $1.87$28K
NUVB
Nuvation Bio Inc.
Nov 19, 2025
Sale(S)
Direct
15K shares at avg. $5.10$77K
NUVB
Nuvation Bio Inc.
Nov 17, 2025
Sale(S)
Direct
15K shares at avg. $4.76$71K
NUVB
Nuvation Bio Inc.
Nov 17, 2025
Exercise(M)
Direct
15K shares at avg. $1.87$28K
NUVB
Nuvation Bio Inc.
May 2, 2025
Exercise(M)
Direct
20K shares at avg. $1.94$39K
NUVB
Nuvation Bio Inc.
May 2, 2025
Sale(S)
Direct
20K shares at avg. $2.50$50K
NUVB
Nuvation Bio Inc.
Feb 28, 2025
Award(A)
Stock Option (Right to Buy)
Direct
500K shares-

		Type	Shares	Price		Ownership
Apr 17, 2026	NUVB Nuvation Bio Inc.	Exercise(M)	50,000	$1.94	$97,000	Direct
Apr 17, 2026	NUVB Nuvation Bio Inc.	Sale(S)	50,000	$5.02	$251,000	Direct
Feb 27, 2026	NUVB Nuvation Bio Inc.	Award(A) Stock Option (Right to Buy)	748,130	-	-	Direct
Dec 1, 2025	NUVB Nuvation Bio Inc.	Sale(S)	150,000	$7.82	$1,173,255	Direct
Dec 1, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	150,000	$2.93	$439,500	Direct
Nov 26, 2025	NUVB Nuvation Bio Inc.	Sale(S)	10,000	$8.00	$80,000	Direct
Nov 26, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	10,000	$3.61	$36,100	Direct
Nov 25, 2025	NUVB Nuvation Bio Inc.	Sale(S)	10,000	$7.50	$75,000	Direct
Nov 25, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	10,000	$3.61	$36,100	Direct
Nov 20, 2025	NUVB Nuvation Bio Inc.	Sale(S)	20,000	$7.00	$140,074	Direct
Nov 20, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	20,000	$1.87	$37,400	Direct
Nov 19, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	15,000	$1.87	$28,050	Direct
Nov 19, 2025	NUVB Nuvation Bio Inc.	Sale(S)	15,000	$5.10	$76,553	Direct
Nov 17, 2025	NUVB Nuvation Bio Inc.	Sale(S)	15,000	$4.76	$71,475	Direct
Nov 17, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	15,000	$1.87	$28,050	Direct
May 2, 2025	NUVB Nuvation Bio Inc.	Exercise(M)	20,000	$1.94	$38,800	Direct
May 2, 2025	NUVB Nuvation Bio Inc.	Sale(S)	20,000	$2.50	$50,024	Direct
Feb 28, 2025	NUVB Nuvation Bio Inc.	Award(A) Stock Option (Right to Buy)	500,000	-	-	Direct

1-18 of 18 transactions

About Liu Dongfang

Liu Dongfang (SEC CIK 0001937915) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Nuvation Bio Inc. (NUVB).

Signal8 holds 8 ownership filings by Liu Dongfang, all Form 4s, filed between Mar 4, 2025 and Apr 21, 2026. Those filings report 18 transactions, from Feb 28, 2025 to Apr 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Liu Dongfang's filings is in NEW YORK, NY.

Recent filings by Liu Dongfang

Apr 17, 2026: Option exercise of NUVB shares (Form 4, code M).
Apr 17, 2026: Open-market sale of NUVB shares (Form 4, code S).
Feb 27, 2026: Grant or award of NUVB derivative securities (Form 4, code A).
Dec 1, 2025: Open-market sale of NUVB shares (Form 4, code S).
Dec 1, 2025: Option exercise of NUVB shares (Form 4, code M).

Other insiders filing for Nuvation Bio Inc. (NUVB)

Hattersley Gary, CHIEF SCIENTIFIC OFFICER
Sauvage Philippe, Chief Financial Officer
Markel Stacy, CHIEF PEOPLE OFFICER
Wentworth Kerry, CHIEF REGULATORY OFFICER
Mashal Robert, Director
VERNON W ANTHONY, Director

How to read Form 4 transaction codes